AI assistant
NeuroPace Inc — Director's Dealing 2021
Apr 20, 2021
33194_dirs_2021-04-20_c9d57b5e-78e6-40a6-b808-f529f11ce93e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NeuroPace Inc (NPCE)
CIK: 0001528287
Period of Report: 2021-04-20
Reporting Person: Morrell Martha (Chief Medical officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1518 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $0.03 | 2030-10-29 | Common Stock (278846) | Direct | |
| Stock Option (Right to Buy) | $0.03 | 2024-10-12 | Common Stock (192) | Direct | |
| Stock Option (Right to Buy) | $0.03 | 2022-11-13 | Common Stock (192) | Direct | |
| Stock Option (Right to Buy) | $0.03 | 2021-07-05 | Common Stock (192) | Direct | |
| Stock Option (Right to Buy) | $0.03 | 2023-03-06 | Common Stock (384) | Direct | |
| Stock Option (Right to Buy) | $0.03 | 2027-12-01 | Common Stock (12234) | Direct | |
| Stock Option (Right to Buy) | $0.03 | 2025-07-23 | Common Stock (192) | Direct | |
| Stock Option (Right to Buy) | $0.03 | 2024-04-21 | Common Stock (192) | Direct |
Footnotes
F1: 1/48th of the shares subject to the option vest in equal monthly installments commencing September 19, 2020. If, at the time of the initial public offering, less than 232,371 of the shares subject to this option remain unvested, an amount of shares subject to this option shall vest and become immediately exercisable immediately prior to the offering such that a total of 232,371 shares subject to this option will be vested and immediately exercisable, subject to Dr. Morrells continued service with NeuroPace, Inc. Following such acceleration, the remaining unvested shares subject to this option will continue to vest in equal monthly installments over 48 months.
F2: 25% of the shares subject to the option vest on July 1, 2015; 1/48th of the shares subject to the option vest in 36 equal monthly installments thereafter.
F3: 25% of the shares subject to the option vest on July 1, 2013; 1/48th of the shares subject to the option vest in 36 equal monthly installments thereafter.
F4: 25% of the shares subject to the option vest on July 1, 2012; 1/48th of the shares subject to the option vest in 36 equal monthly installments thereafter.
F5: The shares underlying the option are fully vested.
F6: 1/48th of the shares subject to the option vest in equal monthly installments commencing February 1, 2017.
F7: 25% of the shares subject to the option vest on July 1, 2016; 1/48th of the shares subject to the option vest in 36 equal monthly installments thereafter.
F8: 25% of the shares subject to the option vest on July 1, 2014; 1/48th of the shares subject to the option vest in 36 equal monthly installments thereafter.